Where have all the T cells gone? Mechanisms of immune evasion by tumors

被引：141

作者：

Finke, J

Ferrone, S

Frey, A

Mufson, A

Ochoa, A

机构：

[1] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA

[2] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA

[3] NYU, Dept Cell Biol, Ctr Med, New York, NY 10016 USA

[4] NCI, Canc Immunol Branch, Bethesda, MD 20892 USA

[5] Louisiana State Univ, Med Ctr, New Orleans, LA 70112 USA

来源：

IMMUNOLOGY TODAY | 1999年 / 20卷 / 04期

关键词：

D O I：

10.1016/S0167-5699(98)01435-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The immune system of tumor-bearing patients and experimental animals is adversely affected by the tumor, even early in the course of disease. A recent meeting* focused on the mechanisms involved in this phenomenon and their implications for cancer immunotherapy.

引用

收藏

页码：158 / 160

页数：3

相关论文

共 15 条

[1]

FRANCO JL, 1995, CANCER RES, V55, P3840

[2] Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation [J].

Kersh, EN ;

Shaw, AS ;

Allen, PM .

SCIENCE, 1998, 281 (5376) :572-575

[3] T-CELLS FROM LATE TUMOR-BEARING MICE EXPRESS NORMAL LEVELS OF P56(LCK), P59(FYN), ZAP-70, AND CD3-ZETA DESPITE SUPPRESSED CYTOLYTIC ACTIVITY [J].

LEVEY, DL ;

SRIVASTAVA, PK .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1029-1036

[4] Impaired activation of NFΚB in T cells from a subset of renal cell carcinoma patients is mediated by inhibition of phosphorylation and degradation of the inhibitor, IΚBα [J].

Ling, WJ ;

Rayman, P ;

Uzzo, R ;

Clark, P ;

Kim, HJ ;

Tubbs, R ;

Novick, A ;

Bukowski, R ;

Hamilton, T ;

Finke, J .

BLOOD, 1998, 92 (04) :1334-1341

[5] Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes [J].

Lopez, CB ;

Rao, TD ;

Feiner, H ;

Shapiro, R ;

Marks, JR ;

Frey, AB .

CELLULAR IMMUNOLOGY, 1998, 190 (02) :141-155

[6]

Matsuda M, 1998, SCAND J IMMUNOL, V47, P254

[7] Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigens [J].

Melero, I ;

Bach, N ;

Chen, LP .

LIFE SCIENCES, 1997, 60 (23) :2035-2041

[8]

Petersson M, 1998, J IMMUNOL, V161, P2099

[9] Mechanisms responsible for signaling and functional defects [J].

Reichert, TE ;

Rabinowich, H ;

Johnson, JT ;

Whiteside, TL .

JOURNAL OF IMMUNOTHERAPY, 1998, 21 (04) :295-306

[10] TAP off - Tumors on [J].

Seliger, B ;

Maeurer, MJ ;

Ferrone, S .

IMMUNOLOGY TODAY, 1997, 18 (06) :292-299